Stockscreener 앱 받기
2.24
4.49%
0.125
전일 마감가:
$2.115
열려 있는:
$2.19
하루 거래량:
114.72K
Relative Volume:
0.23
시가총액:
$281.60M
수익:
-
순이익/손실:
$-70.78M
주가수익비율:
-4.00
EPS:
-0.56
순현금흐름:
$-61.27M
1주 성능:
+22.78%
1개월 성능:
+55.63%
6개월 성능:
+181.67%
1년 성능:
-7.14%
1일 변동 폭
$2.0665
$2.24
1주일 범위
$1.80
$2.54
52주 변동 폭
$0.62
$2.54
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
명칭
Nautilus Biotechnology Inc
전화
206-333-2001
주소
2701 EASTLAKE AVE EAST, SEATTLE
NAUT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.2295 | 267.14M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.34 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
747.89 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.80 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
919.59 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.60 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-05 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-06-27 | 개시 | Guggenheim | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2022-01-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-11-02 | 개시 | Cowen | Outperform |
| 2021-08-04 | 개시 | Goldman | Neutral |
| 2021-07-13 | 개시 | Jefferies | Buy |
모두보기
Nautilus Biotechnology Inc 주식(NAUT)의 최신 뉴스
There is no way Nautilus Biotechnology Inc (NAUT) can keep these numbers up - Setenews
Advanced analytics toolkit walkthrough for Nautilus Biotechnology Inc.2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
What dividend safety score for Nautilus Biotechnology Inc. stockMarket Growth Report & Low Volatility Stock Recommendations - newser.com
Long term hold vs stop loss in Nautilus Biotechnology Inc.Market Risk Summary & Daily Profit Focused Stock Screening - newser.com
Will Nautilus Biotechnology Inc. stock maintain momentum in 2025Recession Risk & Low Drawdown Investment Ideas - newser.com
Has Nautilus Biotechnology Inc. found a price floorMarket Growth Summary & Free High Accuracy Swing Entry Alerts - newser.com
What candlestick patterns are forming on Nautilus Biotechnology Inc.Weekly Trend Recap & Reliable Price Breakout Signals - newser.com
Will Nautilus Biotechnology Inc. stock outperform value stocksMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is recommended by analystsMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Wall Street Zen Upgrades Nautilus Biotechnology (NASDAQ:NAUT) to Hold - Defense World
How to recover losses in Nautilus Biotechnology Inc. stockBull Run & Technical Entry and Exit Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is considered a top pickMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Nautilus Biotechnology Inc. stock oversold or undervaluedEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
How Nautilus Biotechnology Inc. stock performs in rate cut cyclesPortfolio Update Report & Community Trade Idea Sharing Platform - newser.com
How geopolitical tensions affect Nautilus Biotechnology Inc. stock2025 Breakouts & Breakdowns & Real-Time Volume Triggers - newser.com
Published on: 2025-11-13 14:26:20 - newser.com
Strategies to average down on Nautilus Biotechnology Inc.Trade Entry Report & Weekly Stock Breakout Alerts - newser.com
Can Nautilus Biotechnology Inc. stock weather global recessionBuy Signal & High Conviction Buy Zone Alerts - newser.com
Suzuki Kentaro buys Nautilus Biotechnology shares worth $5,960 By Investing.com - Investing.com Canada
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Officer Suzuki Buys 4,000 ($6K) Of Nautilus Biotechnology Inc [NAUT] - TradingView
Wall Street Zen Downgrades Nautilus Biotechnology (NASDAQ:NAUT) to Sell - Defense World
Nautilus Biotechnology redefines proteomics at HUPO2025 - Traders Union
Is this a good reentry point in Nautilus Biotechnology Inc.Share Buyback & Precise Trade Entry Recommendations - newser.com
Nautilus announces installation, testing of its external field evaluation unit - MSN
Nautilus Biotechnology Inc (NAUT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nautilus Biotechnology Inc 주식 (NAUT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Patel Sujal M | CEO, President, and Secretary |
Sep 05 '25 |
Buy |
0.67 |
116,500 |
78,544 |
10,258,221 |
| Patel Sujal M | CEO, President, and Secretary |
Sep 08 '25 |
Buy |
0.68 |
83,500 |
57,031 |
10,341,721 |
| Murphy Matthew B. | General Counsel |
Sep 04 '25 |
Buy |
0.64 |
20,000 |
12,858 |
74,140 |
| Mowry Anna | CFO and Treasurer |
May 29 '25 |
Buy |
0.77 |
15,000 |
11,488 |
83,000 |
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
1.07%
1.18%
자본화:
|
볼륨(24시간):